A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
Recruiting
Observational Study
COVID-19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250,000 (estimated)
- Sponsor
- Ruijin Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is to clarify the distribution characteristics, host and clinical characteristics, disease outcome and risk factors, changes of multiple organs such as cardiopulmonary function and changes in social and psychological indicators during long-term follow-up of omicron variant asymptomatic infections and diagnosed patients
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* SARS-Cov-2-RNA positive
* informed consent signed
Exclusion Criteria:
* informed consent rejected
Contacts